REVENUE MEMORANDUM CIRCULAR NO. 101-2020 issued on September 25, 2020 publishes the full text of the letter from the Food and Drug Administration of the Department of Health containing the “Addendum to the List of VAT-Exempt Drugs for Hypertension, Diabetes and High Cholesterol” pursuant to Republic Act No. 11467.